<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(11)</volume><submitter>Grohova A</submitter><pubmed_abstract>Myeloid-derived suppressor cells (MDSC) represent a heterogeneous group of immature myeloid cells with immunoregulatory function in cancer and autoimmune diseases. In humans, two subsets of MDSC were determined based on the characteristic surface markers, monocytic MDSC (M-MDSC) and granulocytic MDSC (G-MDSC). Expansion of MDSC has been reported in some murine models and patients with autoimmune diseases and their immune-suppressive properties were characterized. However, the exact role of MDSC in the pathogenesis of autoimmune diseases is more complex and/or controversial. In type 1 diabetes mellitus (T1D), the increased frequency of MDSC was found in the blood of T1D patients but their suppressor capacity was diminished. In our study, we assessed the role of M-MDSC in the pathogenesis of</pubmed_abstract><journal>PloS one</journal><pagination>e0242092</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7673497</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.</pubmed_title><pmcid>PMC7673497</pmcid><pubmed_authors>Danova K</pubmed_authors><pubmed_authors>Adkins I</pubmed_authors><pubmed_authors>Obermannova B</pubmed_authors><pubmed_authors>Palova-Jelinkova L</pubmed_authors><pubmed_authors>Spisek R</pubmed_authors><pubmed_authors>Sumnik Z</pubmed_authors><pubmed_authors>Grohova A</pubmed_authors><pubmed_authors>Kolouskova S</pubmed_authors><pubmed_authors>Petruzelkova L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.</name><description>Myeloid-derived suppressor cells (MDSC) represent a heterogeneous group of immature myeloid cells with immunoregulatory function in cancer and autoimmune diseases. In humans, two subsets of MDSC were determined based on the characteristic surface markers, monocytic MDSC (M-MDSC) and granulocytic MDSC (G-MDSC). Expansion of MDSC has been reported in some murine models and patients with autoimmune diseases and their immune-suppressive properties were characterized. However, the exact role of MDSC in the pathogenesis of autoimmune diseases is more complex and/or controversial. In type 1 diabetes mellitus (T1D), the increased frequency of MDSC was found in the blood of T1D patients but their suppressor capacity was diminished. In our study, we assessed the role of M-MDSC in the pathogenesis of</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-22T14:38:07.831Z</modification><creation>2021-02-19T11:47:40Z</creation></dates><accession>S-EPMC7673497</accession><cross_references><pubmed>33206686</pubmed><doi>10.1371/journal.pone.0242092</doi></cross_references></HashMap>